Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-856 Cr₹-288 Cr₹122 Cr₹122 Cr₹128 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA is ₹-856 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-856 Cr
Mar2023₹-288 Cr
Mar2022₹122 Cr
Mar2021₹122 Cr
Mar2020₹128 Cr

How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-856 Cr
Negative
Mar2023 ₹-288 Cr
Negative
Mar2022 ₹122 Cr
0.40
Mar2021 ₹122 Cr
-5.14
Mar2020 ₹128 Cr -

Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹64,439.8 Cr -4.4% -8% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,614.0 Cr -2.5% -4.7% 11.9% Stock Analytics
DIVIS LABORATORIES ₹173,533.0 Cr -2.7% -0.7% 50.4% Stock Analytics
CIPLA ₹121,439.0 Cr -1.2% 0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹110,076.0 Cr -2.3% 8.2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,066.0 Cr 1.4% -1.5% 13.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.4%

-8%

-8.3%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses